Cargando…

Predicting mammographic density with linear ultrasound transducers

BACKGROUND: High mammographic density (MD) is a risk factor for the development of breast cancer (BC). Changes in MD are influenced by multiple factors such as age, BMI, number of full-term pregnancies and lactating periods. To learn more about MD, it is important to establish non-radiation-based, a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Behrens, Annika, Fasching, Peter A., Schwenke, Eva, Gass, Paul, Häberle, Lothar, Heindl, Felix, Heusinger, Katharina, Lotz, Laura, Lubrich, Hannah, Preuß, Caroline, Schneider, Michael O., Schulz-Wendtland, Rüdiger, Stumpfe, Florian M., Uder, Michael, Wunderle, Marius, Zahn, Anna L., Hack, Carolin C., Beckmann, Matthias W., Emons, Julius
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10537934/ https://www.ncbi.nlm.nih.gov/pubmed/37770952 http://dx.doi.org/10.1186/s40001-023-01327-9

Ejemplares similares

Mammographic density and prognosis in primary breast cancer patients
por: Heindl, Felix, et al.
Publicado: (2021)

Correlation of mammographic density and serum calcium levels in patients with primary breast cancer
por: Hack, Carolin C., et al.
Publicado: (2017)

Characterizing mammographic images by using generic texture features
por: Häberle, Lothar, et al.
Publicado: (2012)

Using automated texture features to determine the probability for masking of a tumor on mammography, but not ultrasound
por: Häberle, Lothar, et al.
Publicado: (2017)

HLA-G and HLA-F protein isoform expression in breast cancer patients receiving neoadjuvant treatment
por: Wuerfel, Franziska M., et al.
Publicado: (2020)

Analysis of motives and patient satisfaction in oncological second opinions provided by a certified university breast and gynecological cancer center
por: Loehberg, Christian R., et al.
Publicado: (2020)

Galactography with Tomosynthesis Technique (Galactomosynthesis) – Renaissance of a Method?
por: Schulz-Wendtland, Rüdiger, et al.
Publicado: (2018)

RANKL and OPG and their influence on breast volume changes during pregnancy in healthy women
por: Wunderle, Marius, et al.
Publicado: (2020)

Evaluation of automated techniques for extraction of circulating cell-free DNA for implementation in standardized high-throughput workflows
por: Lehle, Sarah, et al.
Publicado: (2023)

Prediction of pathological complete response and prognosis in patients with neoadjuvant treatment for triple-negative breast cancer
por: Gass, Paul, et al.
Publicado: (2018)

Risk, Prediction and Prevention of Hereditary Breast Cancer – Large-Scale Genomic Studies in Times of Big and Smart Data
por: Wunderle, Marius, et al.
Publicado: (2018)

Cost effectiveness of bilateral risk-reducing mastectomy and salpingo-oophorectomy
por: Schrauder, Michael G., et al.
Publicado: (2019)

Assessment of the additional clinical potential of X-ray dark-field imaging for breast cancer in a preclinical setup
por: Emons, Julius, et al.
Publicado: (2020)

Polymorphisms in the RANK/RANKL Genes and Their Effect on Bone Specific Prognosis in Breast Cancer Patients
por: Hein, Alexander, et al.
Publicado: (2014)

Discordance between Primary Breast Cancer and Ipsilateral Breast Cancer Tumor Recurrence as a Function of Distance
por: Jud, Sebastian M., et al.
Publicado: (2020)

Comprehensive characterization of endometriosis patients and disease patterns in a large clinical cohort
por: Blum, Simon, et al.
Publicado: (2021)

PIWI-Like 1 and PIWI-Like 2 Expression in Breast Cancer
por: Erber, Ramona, et al.
Publicado: (2020)

Improving the Quality of Care for Cancer Patients through Oncological Second Opinions in a Comprehensive Cancer Center: Feasibility of Patient-Initiated Second Opinions through a Health-Insurance Service Point
por: Schulmeyer, Carla E., et al.
Publicado: (2023)

Clinical Characteristics and Prognosis of HER2-0 and HER2-Low-Positive Breast Cancer Patients: Real-World Data from Patients Treated with Neoadjuvant Chemotherapy
por: Pöschke, Patrik, et al.
Publicado: (2023)

Impact of fibroblast growth factor receptor 1 (FGFR1) amplification on the prognosis of breast cancer patients
por: Erber, Ramona, et al.
Publicado: (2020)

Saliva samples as a source of DNA for high throughput genotyping: an acceptable and sufficient means in improvement of risk estimation throughout mammographic diagnostics
por: Poehls, U. G., et al.
Publicado: (2018)

Standards Used by a Clinical and Scientific Endometriosis Center for the Diagnosis and Therapy of Patients with Endometriosis
por: Burghaus, Stefanie, et al.
Publicado: (2019)

Variable Expression of the Disialoganglioside GD2 in Breast Cancer Molecular Subtypes
por: Erber, Ramona, et al.
Publicado: (2021)

Low-Risk Women with Suspicious Microcalcifications in Mammography—Can an Additional Breast MRI Reduce the Biopsy Rate?
por: Pöschke, Patrik, et al.
Publicado: (2023)

Multicentre evaluation of stereotactic vacuum biopsies of mammographically indeterminate or suspicious lesions
por: Schulz-Wendtland, R, et al.
Publicado: (2002)

Endometriosis as a risk factor for ovarian or endometrial cancer — results of a hospital-based case–control study
por: Burghaus, Stefanie, et al.
Publicado: (2015)

Expression of the Immunohistochemical Markers CK5, CD117, and EGFR in Molecular Subtypes of Breast Cancer Correlated with Prognosis
por: Schulmeyer, Carla E., et al.
Publicado: (2023)

Breast MRI texture analysis for prediction of BRCA-associated genetic risk
por: Vasileiou, Georgia, et al.
Publicado: (2020)

Using Probability for Pathological Complete Response (pCR) as a Decision Support Marker for Neoadjuvant Chemotherapy in HER2 Negative Breast Cancer Patients – a Survey Among Physicians
por: Gass, Paul, et al.
Publicado: (2018)

Ki67, chemotherapy response, and prognosis in breast cancer patients receiving neoadjuvant treatment
por: Fasching, Peter A, et al.
Publicado: (2011)

Ex Vivo Chromosomal Radiosensitivity Testing in Patients with Pathological Germline Variants in Breast Cancer High-Susceptibility Genes BReast CAncer 1 and BReast CAncer 2
por: Zuhair Kassem, Tara, et al.
Publicado: (2023)

Implementation of machine learning into clinical breast MRI: Potential for objective and accurate decision-making in suspicious breast masses
por: Ellmann, Stephan, et al.
Publicado: (2020)

Mammographic screening and mammographic patterns
por: Day, Nick, et al.
Publicado: (2000)

Mammographic density. Measurement of mammographic density
por: Yaffe, Martin J
Publicado: (2008)

SARS-CoV-2 Infection in Pregnancy – a Review of the Current Literature and Possible Impact on Maternal and Neonatal Outcome
por: Stumpfe, Florian M., et al.
Publicado: (2020)

Prevalence of SARS-CoV-2 in Pregnant Women Assessed by RT-PCR in Franconia, Germany: First Results of the SCENARIO Study (SARS-CoV-2 prEvalence in pregNAncy and at biRth In FrancOnia)
por: Hein, Alexander, et al.
Publicado: (2022)

Mammographic density
por: Boyd, Norman F, et al.
Publicado: (2009)

Macromastia: an economic burden? A disease cost analysis based on real-world data in Germany
por: Jud, Sebastian M., et al.
Publicado: (2020)

Breast MRI in the era of diffusion weighted imaging: do we still need signal-intensity time curves?
por: Dietzel, Matthias, et al.
Publicado: (2019)

Detection of Microcalcifications in Spiral Breast Computed Tomography with Photon-Counting Detector Is Feasible: A Specimen Study
por: Wetzl, Matthias, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_543dlfis597tmitibf1dnlbf1j